Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents Article

Tong, XW, Shine, DH, Agoulnik, I et al. (1998). Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents . ANTICANCER RESEARCH, 18(5A), 3421-3426.

International Collaboration

cited authors

  • Tong, XW; Shine, DH; Agoulnik, I; Freund, CTF; Hasenburg, A; Aguilar-Cordova, E; Woo, SLC; Kieback, DG

sustainable development goals

authors

publication date

  • September 1, 1998

published in

keywords

  • CAMPTOTHECIN
  • CISPLATIN
  • COLORIMETRIC ASSAY
  • DNA TOPOISOMERASE-I
  • GANCICLOVIR
  • IONIZING-RADIATION
  • LINES
  • Life Sciences & Biomedicine
  • MTT assay
  • Oncology
  • Science & Technology
  • TOPOTECAN
  • TRANSDUCTION
  • antagonism
  • chemotherapy
  • gene therapy
  • ovarian cancer
  • synergistic interaction

publisher

  • INT INST ANTICANCER RESEARCH

start page

  • 3421

end page

  • 3426

volume

  • 18

issue

  • 5A